Antibodies taken from alpacas are to be used in a new pandemic flu drug, in a £33 million project led by AstraZenica.

Researchers developed an alpaca-derived antibody that could lead to a cheaper and more effective therapeutic option for the Omicron variant of the novel coronavirus. The team from Kyoto University ...

The German company NanoTag Biotechnologies has purchased from The Austral University of Chile (AUCh) the marketing license for the W25 antibody, it was announced Friday in Santiago. The ...